Alcyone™ Technology , a major breakthrough revolutionizing Nuclear Cardiology since the introduction of the Anger camera in the late 50’s.
This technology was first announced to the Nuclear Cardiology community in May 2009, at the 9th International Congress of Nuclear Cardiology. It was also presented last year to the whole Cardiology community during the ESC’09.
Alcyone Technology combines Cadmium Zinc Telluride (CZT) solid-state multi-detectors focused on the heart, 3D reconstruction and stationary data acquisition.
It has the ability to reduce scan time from 15-20 min to 3-5 min, thus increasing efficiency and diagnostic confidence: a shorter scan gives an opportunity to improve image quality by reducing motion artefacts. This drastic reduction in acquisition time can also provide more flexibility in dose management, and potentially open new perspectives in Nuclear Cardiology.
The Alcyone Technology-based nuclear cardiology platform includes two systems:
Discovery NM 530c, the SPECT-only system providing high efficiency and improved patient experience.
Discovery NM/CT 570c, the integrated version of the Discovery NM 530c with the LightSpeed VCT. It has the ability to perform a complete functional and anatomical cardiac assessment in less than five minutes. In addition to higher throughput and more flexible dose management, this configuration enables more convenient patient scheduling in comparison to two separate, conventional SPECT and CT exams.
Building a growth framework for nuclear cardiology departments to evolve with changing patients needs, GE Healthcare provides clinicians the flexibility to tailor their equipment platform to their economical and clinical needs. The launch of Alycone Technology introduces a practical upgrade pathway from Ventri, the dedicated conventional nuclear cardiology camera, to the Discovery NM 530c and Discovery NM/CT 570c systems.
Learn more about Alcyone™ Technology
GE Healthcare at ESC 2010: Helping you address the challenges in Coronary Artery Disease
Nuclear cardiology tools are vital to our understanding and treatment of heart-related illnesses. Thanks for posting this article.
Thanks,
Trina
Posted by: TrinaPhoenix | Tuesday, March 16, 2010 at 04:38
Yes, I agree with Trina. These facilities need to be widely adopted by healthcare industry.
Posted by: Medical oncology in India | Wednesday, May 19, 2010 at 17:23